Top compounds associated with response to CHRD


Feature Type Standardized
Nominal ANOVA
mRNA thapsigargin gCSI pan-cancer AAC -0.17 0.003
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.003
mRNA Parthenolide CTRPv2 pan-cancer AAC 0.11 0.004
mRNA Vandetanib CTRPv2 pan-cancer AAC -0.1 0.004
mRNA BRD-K16130065 CTRPv2 pan-cancer AAC 0.2 0.005
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.094 0.006
mRNA erismodegib CTRPv2 pan-cancer AAC 0.1 0.007
mRNA BRD-K58730230 CTRPv2 pan-cancer AAC 0.19 0.007
mRNA CHEMBL1222381 CTRPv2 pan-cancer AAC 0.087 0.008
mRNA YL54 CTRPv2 pan-cancer AAC 0.1 0.009
Download CSV